These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7899248)

  • 21. A semi-physiologically-based pharmacokinetic model characterizing mechanism-based auto-inhibition to predict stereoselective pharmacokinetics of verapamil and its metabolite norverapamil in human.
    Wang J; Xia S; Xue W; Wang D; Sai Y; Liu L; Liu X
    Eur J Pharm Sci; 2013 Nov; 50(3-4):290-302. PubMed ID: 23916407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chiral capillary electrophoretic analysis of verapamil metabolism by cytochrome P450 3A4.
    Ha PT; Sluyts I; Van Dyck S; Zhang J; Gilissen RA; Hoogmartens J; VanSchepdael A
    J Chromatogr A; 2006 Jul; 1120(1-2):94-101. PubMed ID: 16376901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene.
    Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
    Can J Physiol Pharmacol; 2008 May; 86(5):232-9. PubMed ID: 18432283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic interaction between verapamil and metoprolol in the dog. Stereochemical aspects.
    Murthy SS; Nelson WL; Shen DD; Power JM; Cahill CM; McLean AJ
    Drug Metab Dispos; 1991; 19(6):1093-100. PubMed ID: 1687016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective renal tubular secretion of an organic anion in the isolated perfused rat kidney.
    Higaki K; Kadono K; Goto S; Nakano M
    J Pharmacol Exp Ther; 1994 Jul; 270(1):329-35. PubMed ID: 8035328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enantioselective disposition and protein binding of [(5,6-dichloro-9a-propyl-3-oxo-2,3,9,9a-tetrahydro-1-H-fluoren-7 -yl)-oxy] acetic acid, a new cerebral antiedemic agent, in rats.
    Lin JH; Hsieh JY
    Drug Metab Dispos; 1988; 16(4):540-5. PubMed ID: 2903020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (S)-4'-hydroxypropranolol causes product inhibition and dose-dependent bioavailability of propranolol enantiomers in the isolated perfused rat liver and in rat liver microsomes.
    Nand RA; Ghabrial H; Smallwood RA; Morgan DJ
    Xenobiotica; 1996 Dec; 26(12):1249-61. PubMed ID: 9004455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines.
    Häussermann K; Benz B; Gekeler V; Schumacher K; Eichelbaum M
    Eur J Clin Pharmacol; 1991; 40(1):53-9. PubMed ID: 2060546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing.
    Johnson LM; Lankford SM; Bai SA
    J Vet Pharmacol Ther; 1995 Apr; 18(2):117-23. PubMed ID: 7629925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into stereoselective disposition of enantiomers of a potent antithrombotic agent, S002-333 following administration of the racemic compound to mice.
    Bhateria M; Rachumallu R; Yerrabelli S; Saxena AK; Bhatta RS
    Eur J Pharm Sci; 2017 Apr; 101():107-114. PubMed ID: 28189817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enantioselective transport and CYP3A4-mediated metabolism of R/S-verapamil in Caco-2 cell monolayers.
    Engman H; Tannergren C; Artursson P; Lennernäs H
    Eur J Pharm Sci; 2003 May; 19(1):57-65. PubMed ID: 12729862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites.
    Wang YH; Jones DR; Hall SD
    Drug Metab Dispos; 2004 Feb; 32(2):259-66. PubMed ID: 14744949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enantioselective tissue distribution of the basic drugs disopyramide, flecainide and verapamil in rats: role of plasma protein and tissue phosphatidylserine binding.
    Hanada K; Akimoto S; Mitsui K; Mihara K; Ogata H
    Pharm Res; 1998 Aug; 15(8):1250-6. PubMed ID: 9706057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat.
    Laethem ME; Belpaire FM; Wijnant P; Rosseel MT; Bogaert MG
    Chirality; 1994; 6(5):405-10. PubMed ID: 8068500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.
    Tannergren C; Engman H; Knutson L; Hedeland M; Bondesson U; Lennernäs H
    Clin Pharmacol Ther; 2004 Apr; 75(4):298-309. PubMed ID: 15060508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Huang-Lian-Jie-Du-Decoction on pharmacokinetics of verapamil in rats.
    Xie SS; Hu N; Jing XY; Liu XD; Xie L; Wang GJ; Liu CH
    J Pharm Pharmacol; 2010 Apr; 62(4):440-7. PubMed ID: 20604832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereoselectivity in glutathione conjugation and amidase-catalyzed hydrolysis of the 2-bromoisovalerylurea enantiomers in the single-pass perfused rat liver.
    Polhuijs M; Gasinska I; Cherry WF; Mulder GJ; Pang KS
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1406-12. PubMed ID: 8510017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective CZE method for analysis of verapamil and norverapamil in human plasma.
    Resztak M; Główka FK
    Acta Pol Pharm; 2013; 70(3):395-401. PubMed ID: 23757929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of albumin on enantioselective local disposition of BOF-4272, a xanthine oxidase inhibitor with chiral sulfoxide, in rat liver.
    Nishimura M; Yamaoka K; Naito S; Nakagawa T
    Biol Pharm Bull; 1997 Dec; 20(12):1285-9. PubMed ID: 9448105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative prediction of metabolic inhibition of midazolam by erythromycin, diltiazem, and verapamil in rats: implication of concentrative uptake of inhibitors into liver.
    Yamano K; Yamamoto K; Kotaki H; Takedomi S; Matsuo H; Sawada Y; Iga T
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1118-26. PubMed ID: 10688631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.